Fig. 4From: Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patientsTechnical experience of the DecisionDx-SCC test for orders submitted from September 1, 2020 – July 31, 2021. *QC failure = quality control failure (< 40% tumor content); ^QNS = quantity not sufficient (RNA < 5.0 ng/μl)Back to article page